Wegovy: Novo Nordisk Reduces Heart Attack, Stroke Risk in Non-Diabetic Individuals, Study Reveals
New data from an extensive international clinical trial show that Novo Nordisk's well-known weight-loss medication Wegovy significantly reduced the risk of having a stroke, having a heart attack, or dying from cardiovascular disease in…